Molecular Diagnostic Data Characteristics
Molecular diagnostic data originates from in vitro diagnostic (IVD) clinical trial reports, real-world evidence (RWE) data, post-market serious adverse event (SAE) reports, and regulatory risk communications. This data exists in both structured and unstructured formats. It includes clinical study protocols, case report forms (CRFs), laboratory test results, diagnostic device logs, and free-text adverse event descriptions submitted by users. Data update frequency varies by source. Clinical trial data typically updates in batches during study phase reports, while SAE data accumulates continuously. Report structures often follow ICH E2B or MedDRA coding standards. These reports contain fields such as patient demographics, diagnostic methods, test results, adverse event onset time, severity, management actions, and outcomes. Molecular diagnostic data uniquely includes biological specificity fields like gene loci, mutation types, and copy number variations. It may also include raw sequencing files or image data. Units include ng/mL and copies/μL.
Constraints on Reference Tracing
The diversity and specificity of molecular diagnostic data impose several constraints on reference tracing. First, large files like raw sequencing data or high-resolution images require efficient file processing and storage to ensure content integrity during referencing. Second, asynchronous data updates, especially the continuous accumulation of SAE data, necessitate knowledge base support for incremental updates and version management to ensure reference information timeliness. The mix of structured data and unstructured text means that simple text retrieval is insufficient. Semantic understanding and entity recognition technologies are essential to accurately extract and trace specific gene loci or adverse event descriptions. The use of specific coding standards like MedDRA requires the system to identify and interpret these codes during referencing, improving tracing accuracy. Finally, sensitive patient information mandates data anonymization and access control as critical security considerations for reference tracing.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 500 MB | Accommodates large files, such as raw sequencing data, potentially included in molecular diagnostic reports. |
Chunk size (Segment Length) | 800–1200 characters | Balances the completeness of structured fields and free-text descriptions, preventing key information truncation. |
Recall count (Recall Count) | Top 8 entries | Covers more potentially relevant clinical trial reports or SAE records, increasing recall rate. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | Balances recall precision and relevance, reduces the introduction of irrelevant content, and ensures tracing accuracy. |
Rerank result count (Reranked Count) | 5 entries | Optimizes the final presentation order of references, prioritizing the most relevant diagnostic or adverse event reports. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Provides sufficient time for parsing complex reports, such as multi-page PDFs or embedded images. |
Common Pitfalls
- Reference responses contain significant irrelevant content: This occurs when the
Similarity threshold(Similarity Threshold) is set too low, causing the system to recall many molecular diagnostic reports or literature snippets not directly related to the query. - Some molecular diagnostic reports fail to parse or be referenced: This can happen if
UPLOAD_FILE_MAX_SIZEorPARSE_FILE_TIMEOUT_SECONDSparameters are set too low, leading to processing failures for large or complex file formats. - AI answers fail to accurately trace to specific gene loci or adverse event classifications: The root cause is the knowledge base's inability to effectively identify and extract MedDRA codes or gene-specific fields during ingestion, which impacts subsequent retrieval and referencing accuracy.
Verification Steps
- Upload various types and sizes of molecular diagnostic reports. Verify successful parsing and indexing for all.
- Query for specific gene mutations or adverse event symptoms. Check if the AI's cited sources accurately point to specific paragraphs in relevant reports.
- Randomly select several molecular diagnostic adverse event cases. Use the system to query and verify if it correctly recalls and displays the corresponding original SAE reports or clinical study data.
- Examine entries in the knowledge base related to MedDRA codes or gene locus descriptions. Verify their correct identification and indexing to ensure clear presentation during referencing.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.